Mega Genomics Limited (HKG:6667)

Hong Kong · Delayed Price · Currency is HKD

7.15

+0.06 (0.85%)

Jul 31, 2026, 4:08 PM HKT

Mega Genomics Financials Overview

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	247.15	247.15	164.23	151.3	145.73	237.19
Revenue Growth	78.81%	50.49%	8.54%	3.82%	-38.56%	16.71%
Gross Profit	117.36	117.36	119.35	88.3	81.72	166.68
Operating Income	26.57	26.57	48.12	26.71	-24.4	108.69
Net Income	27.02	27.02	45.05	30.04	-17.62	79.02
Earnings Per Share	0.14	0.14	0.22	0.14	-0.09	0.62
EPS Growth	-17.29%	-36.98%	53.11%	-	-	-

Cash & Debt

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Investments	438.36	438.36	493.16	526.27	408.53	462.63
Total Debt	29.37	29.37	34.4	48.56	10.99	11.57
Net Cash (Debt)	408.99	408.99	458.75	477.71	397.55	451.06
Net Cash Growth	-2.53%	-10.85%	-3.97%	20.16%	-11.86%	135.56%
Net Cash Per Share	2.07	2.07	2.21	2.26	1.93	3.54

Cash Flow & CapEx

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Operating Cash Flow	-16.52	-16.52	57.15	163.68	-6.91	30.63
Capital Expenditures	-0.16	-0.16	-0.76	-35.86	-5.01	-4.16
Free Cash Flow	-16.68	-16.68	56.39	127.83	-11.92	26.47
Free Cash Flow Growth	-	-	-55.89%	-	-	-74.00%

Margins

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Gross Margin	47.48%	47.48%	72.67%	58.36%	56.08%	70.27%
Operating Margin	10.75%	10.75%	29.30%	17.66%	-16.75%	45.83%
Pretax Margin	13.28%	13.28%	32.66%	23.91%	-14.70%	40.42%
Profit Margin	10.93%	10.93%	27.43%	19.85%	-12.09%	33.31%
FCF Margin	-6.75%	-6.75%	34.34%	84.49%	-8.18%	11.16%

Dividends

Fiscal Year	Current	FY 2025
Period Ending	Aug '26 Aug 1, 2026	Dec '25 Dec 31, 2025
Dividend Per Share	0.174	0.150
Dividend Per Share Growth	0%	-
Dividend Yield	2.44%	2.38%

Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug '26 Aug 1, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
PE Ratio	46.95	53.71	52.26	74.01	-	-
Forward PE	-	9.77	9.77	9.77	14.29	-
P/FCF Ratio	-	-	41.74	17.39	-	-
PS Ratio	5.83	5.87	14.33	14.69	18.88	-